Abstract
Formal homologation of sp2-hybridized boronic acids is achieved via cross-coupling of boronic acids with conjunctive haloaryl BMIDA components in the presence of a suitably balanced basic phase. The utility of this approach to provide a platform for diversity-oriented synthesis in discovery medicinal chemistry is demonstrated in the context of the synthesis of a series of analogues of a BET bromodomain inhibitor.
| Original language | English |
|---|---|
| Pages (from-to) | 6030-6033 |
| Number of pages | 4 |
| Journal | Organic Letters |
| Volume | 17 |
| Issue number | 24 |
| Early online date | 3 Dec 2015 |
| DOIs | |
| Publication status | Published - 18 Dec 2015 |
Keywords
- Boronic acids
- Chemical reactivity
- Organometallic reagents